Which statement describes a treatment goal when using the EV3 Foxhollow Silverhawk?

Which statement describes a treatment goal when using the EV3 Foxhollow Silverhawk?

• A. Treatment of critical limb ischemia and limb salvage
• B. Management of stable angina
• C. Prevention of stroke
• D. Treatment of deep vein thrombosis

Answer: (A)

This device is used to treat limb-threatening peripheral artery disease by debulking plaque in the leg arteries to restore blood flow and save the limb. The SilverHawk/EV3 system is a peripheral atherectomy catheter designed to remove plaque from diseased peripheral vessels, most commonly in the femoropopliteal segment, to increase the lumen and improve distal perfusion. The primary goal in this context is revascularization to prevent amputation in patients with critical limb ischemia or severe PAD. That’s why this option fits best: it targets restoring flow in the leg to salvage the limb. It isn’t used to treat stable angina in the coronary arteries, isn’t aimed at stroke prevention, and isn’t a treatment for deep vein thrombosis, which involves a venous process rather than peripheral arterial debulking.

This device is used to treat limb-threatening peripheral artery disease by debulking plaque in the leg arteries to restore blood flow and save the limb. The SilverHawk/EV3 system is a peripheral atherectomy catheter designed to remove plaque from diseased peripheral vessels, most commonly in the femoropopliteal segment, to increase the lumen and improve distal perfusion. The primary goal in this context is revascularization to prevent amputation in patients with critical limb ischemia or severe PAD.

That’s why this option fits best: it targets restoring flow in the leg to salvage the limb. It isn’t used to treat stable angina in the coronary arteries, isn’t aimed at stroke prevention, and isn’t a treatment for deep vein thrombosis, which involves a venous process rather than peripheral arterial debulking.